Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

VisualDx to Launch AI-Enabled Smart Symptom Checker

VisualDx
Posted on: 16 Aug 18

ROCHESTER, N.Y., Aug. 15, 2018 /PRNewswire/ -- VisualDx, the leading diagnostic clinical decision support tool for physicians, has announced the beginning of a beta test for its new artificial intelligence-driven symptom checker app, Aysa. The new app will allow patients to become more educated and make more informed decisions about their personal skin problems. Aysa is trained through the VisualDx platform which combines clinical search and medical knowledge from experts with a database of more than 120,000 of the best medical images in the world. Using machine learning, Aysa can provide real-time results for skin photos taken in the privacy of a patient's home.

Skin rashes, which can range from annoying but benign to a sign of a serious condition, can look different on different skin types, even if they are the same condition. From psoriasis and eczema to herpes, skin conditions come in different shapes, sizes and severity. By simply taking a photo of one's skin condition and answering a few questions, Aysa will generate a few possible answers in addition to next steps for the iPhone user by suggesting self-care measures or advising a visit with a health care provider. Aysa arms consumers with information and images to better understand skin conditions.

VisualDx is uniquely qualified to bring this app to market. As a physician-led company with a deep knowledge base and understanding of dermatology, VisualDx introduces Aysa as a way to augment health research, but not replace the role of a clinician. In doing so, Aysa does not diagnose. It is able to generate potential diseases and next steps for individuals with common skin conditions, thanks to the power of its world-class medical image library and the use of Apple's CoreML.  

"As a dermatologist, I know my patients are going to Google before coming to see me. But, too often, what they find is not only inaccurate, but dangerous," said Dr. Art Papier, CEO of VisualDx. "Our patients deserve better and Aysa can provide peace of mind to a worried parent and serve as the foundation for a productive visit to the doctor's office. We want people to use their smartphones to get the right answers when they need it most, and for the answers to be drawn from the professional knowledge of physicians."

Beta testing for the Aysa iOS app is now open to select medical professionals and consumers and will be available to the public in early September. For more information, visit www.askaysa.com.

VisualDx is an award-winning diagnostic clinical decision support system and a standard electronic resource at medical schools and in hospital and clinic settings. VisualDx combines clinical search with a database of more than 120,000 of the best medical images in the world, plus medical knowledge from experts to help with diagnosis, treatment, self-education, and patient communication. Expanding to provide diagnostic decision support across general medicine, VisualDx brings increased speed and accuracy to the art of diagnosis. Learn more at www.visualdx.com.

Contact: Kerin Norton, knorton@shiftcomm.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 16/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.